Agilon Health, Inc. (NYSE:AGL) Stock Has Average Price Target of $102.25 According to Analysts

Shares of Agilon Health, Inc. (NYSE:AGL) have received a consensus rating of “Hold” from the fourteen brokerages that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $102.25.

Several equities research analysts recently weighed in on the stock. Robert W. Baird set a $116.00 target price on shares of Agilon Health in a research note on Thursday, August 6th. Royal Bank Of Canada set a $125.00 price target on shares of Agilon Health in a research report on Tuesday, September 15th. Sanford C. Bernstein upgraded shares of Agilon Health from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $86.00 to $125.00 in a research note on Tuesday, September 15th. JPMorgan Chase & Co. upped their price objective on Agilon Health from $31.00 to $85.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. Finally, Benchmark reaffirmed a “buy” rating and set a $140.00 price objective (up from $95.00) on shares of Agilon Health in a research report on Thursday, August 6th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp purchased a new position in shares of Agilon Health in the 2nd quarter valued at about $30,024,000. Rubicon Founders LLC purchased a new stake in shares of Agilon Health during the second quarter worth approximately $11,290,448. Tidal Investments LLC purchased a new stake in shares of Agilon Health during the second quarter worth approximately $1,405,000. Ellsworth Advisors LLC acquired a new stake in Agilon Health in the third quarter valued at approximately $809,000. Finally, Great Lakes Advisors LLC acquired a new stake in Agilon Health in the second quarter valued at approximately $702,000.

Agilon Health Trading Up 2.0%

Shares of NYSE AGL opened at $86.59 on Friday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $1.45 billion, a PE ratio of -6.07 and a beta of 2.98. Agilon Health has a twelve month low of $7.48 and a twelve month high of $133.04. The stock has a fifty day simple moving average of $87.56 and a 200-day simple moving average of $65.18.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. On average, equities analysts forecast that Agilon Health will post -2.90 earnings per share for the current year.

Agilon Health Company Profile

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.

Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.